About CXOur TeamPortfolioPortfolio - North AmericaPortfolio - Asia Pacific
 
 

BIO Management Team

Han-Ton Lim
Chairman & President
Managing Member

Han-Ton Lim is the chairman and managing member of CX Venture Capital Group. Mr. Lim brings in extensive years of senior management experiences in the financial industry throughout the greater China region. Mr. Lim currently sits on the Board of Directors of China Development Investment Bank, the leading and the largest investment bank in Taiwan. Prior to CX Venture Capital Group, Mr. Lim held several senior positions at TCC Hong Kong Cement International Limited, and Shanghai Commercial Bank, Ltd.


Jerome Shen
Managing Member

Jerome Shen, Ph.D., is the Managing Member of CX Venture Group and has over ten years of venture investment experience in the life science industry. Dr. Shen has been actively involved in over 20 investments by taking part-time engagement as President and CEO of the portfolio companies in the startup and post startup stages and by providing business advisory services within the Greater China region. Dr. Shen also holds the position as Secretary General of Taiwan Biotech Association, an organization dedicated to fostering and promoting Taiwan biotechnology industry. Dr. Shen currently sits on several committees of the government funded organizations and research institutions in the biotechnology related field in Taiwan. Prior to joining CX in 1998, Dr. Shen worked on Business Development at Tanox, Inc. Dr. Shen is a member of the Board of Directors for AkriBio, Bioresources International, Cytopharm, Kiotek, Lytone, Level Biotechnologies, and Mycenax. Dr. Shen received his Ph.D. in Chemical Engineering from the University of Wisconsin- Madison and B.S. from Tsinghua University.



Michael Huang
Assistant Vice President


Michael Huang currently serves as manager at CX Venture Capital Group with focus on life sciences investment in the North America regions. Mr. Huang is currently an observer on the Board of Directors for Nellix, Inc., a star-up medical device company focusing on the development of the AAA endografts. Mr. Huang brings several years of experiences in financial/strategic planning and marketing. Prior to joining CX, Mr. Huang took a position as Lead Chemical Engineer at Nan Pao Resins Group where Mr. Huang was responsible for the implementation of ERP programs with several major clients and for the promotion of new water-based adhesive products. Prior to Nan Pao, Mr. Huang was a financial analyst at Continental Airlines¡¦ technical operation group. Mr. Huang received an MS degree in Chemistry from University of Texas at Arlington and an MBA from Rice University.



Louise Chou
Specialist

Louise Chou currently serves as Specialist of CX Venture Group with seven years of working experience in the life science industry.   Ms. Chou also serves as Assistant to Secretary General of Taiwan Biotech Association, a nonprofit organization dedicated to fostering and promoting Taiwan biotechnology industry.   Ms. Chou took several positions at Vita Genomics, Inc, Mendel Health Technology Crop, National Taiwan University Taiwan, and Institute of Economic Research prior to joining CX in 2005.   Ms. Chou received her M.S. and B.S. in Microbiology from Soochow University



Margaret Kuo
Specialist

Margaret Kuo currently serves as Specialist of CX Venture Group with seven years of working experience in the life science industry.   Ms. Kuo served as Associate of incubation center, genomics research center, at Academia Sinica, a preeminent academic institution of R.O.C. Ms. Kuo took several positions at Portal Dunhuang Intangible Asset Appraisal, Inc, the Hong Kong and Shanghai Banking Corp. Ltd., Biotech Industry Force Commission of Taipei City Government, and National Yang Ming University, and joined CX in 2007.  Ms. Kuo received her M.S. and B.S. in Plant pathology and entomology from Nation Taiwan University